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Background: Foot pain is highly prevalent in older people, and in many cases is associated with wearing
inadequate footwear. In Australia, the Department of Veterans’ Affairs (DVA) covers the costs of medical grade
footwear for veterans who have severe foot deformity. However, there is a high demand for footwear by veterans
with foot pain who do not meet this eligibility criterion. Therefore, this article describes the design of a randomized
controlled trial to evaluate the effectiveness of low cost, off-the-shelf footwear in reducing foot pain in DVA
recipients who are currently not eligible for medical grade footwear.
Methods: One hundred and twenty DVA clients with disabling foot pain residing in Melbourne, Australia, who are
not eligible for medical grade footwear will be recruited from the DVA database, and will be randomly allocated to
an intervention group or a ‘usual care’ control group. The intervention group will continue to receive their usual
DVA-subsidized podiatry care in addition to being provided with low-cost, supportive footwear (Dr ComfortW, Vasyli
Medical, Labrador, Queensland, Australia). The control group will also continue to receive DVA-subsidized podiatry
care, but will not be provided with the footwear until the completion of the study. The primary outcome measure
will be pain subscale on the Foot Health Status Questionnaire (FHSQ), measured at baseline and 4, 8, 12 and 16
weeks. Secondary outcome measures measured at baseline and 16 weeks will include the function subscale of the
FHSQ, the Manchester Foot Pain and Disability Index, the number of DVA podiatry treatments required during the
study period, general health-related quality of life (using the Short Form 12W Version 2.0), the number of falls
experienced during the follow-up period, the Timed Up and Go test, the presence of hyperkeratotic lesions (corns
and calluses), the number of participants using co-interventions to relieve foot pain, and participants’ perception of
overall treatment effect. Data will be analyzed using the intention-to-treat principle.
Discussion: This study is the first randomized controlled trial to evaluate the effectiveness of off-the-shelf footwear
in reducing foot pain in DVA recipients. The intervention has been pragmatically designed to ensure that the study
findings can be implemented into policy and clinical practice if found to be effective.
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Foot pain affects approximately one in three people over
the age of 65 years [1-3] and has a significant impact on
quality of life in this age-group. Studies of older people
have demonstrated that foot pain is associated with de-
creased ability to undertake activities of daily living
[4-9], problems with balance and gait [7,10,11] and an
increased risk of falls [12-16]. Furthermore, several
clinic-based studies assessing health-related quality of
life across a range of age-groups have shown that people
with foot disorders (such as generalized foot pain [2,17],
nail infections [18-20], hallux valgus [21,22] hallux
rigidus [23] and plantar heel pain [24]) demonstrate sig-
nificantly lower scores than those without these condi-
tions. A range of risk factors for foot problems has been
identified, including increased age [25-27], female sex
[7,8,26,28], obesity [8,10,28,29], and chronic conditions
such as osteoarthritis and diabetes [8,10,29].
In addition to these risk factors, there is also strong evi-
dence that many older people wear inappropriate or poor
quality footwear, and that ill-fitting footwear may contribute
to foot problems. A household survey of people aged over
80 years conducted in the United Kingdom found that most
wore slippers all day, irrespective of whether they were
housebound [30]. Similarly, a survey of the indoor shoe-
wearing habits of 128 older people in Australia indicated
that more than half spent less than 30 Australian dollars on
their indoor footwear (most commonly slippers), replaced
them infrequently, and often wore their indoor shoes for
outdoor activities [31]. More recently, a survey of sub-acute
aged care hospital patients reported that only 14% wore ‘safe’
footwear, with the most commonly observed detrimental
features being a lack of fastening (86%), slippery soles (86%)
and an excessively flexible heel counter (77%) [32].
By far the most commonly encountered problem with
footwear in older people is the wearing of shoes that are
too small. Burns et al. [33] compared the length and
width of the feet and shoes of 65 people aged between
64 and 93 years attending a rehabilitation ward in the
United Kingdom, and reported that 72% wore shoes of
an incorrect size. Similarly, a study of 440 Veterans’ Af-
fairs patients in the United States reported that only 26%
were found to be wearing appropriately sized shoes [34],
and a recent study of 213 people aged 60 to 80 years in
Thailand reported that 50% of women and 34% of men
wore shoes that were too narrow [35]. Several factors
may be responsible for this, including fashion influences
(particularly in older women [36,37]), not measuring
foot dimensions when purchasing shoes [31], or the ab-
sence of commercially-available, low-cost footwear that
adequately caters for the altered morphology of the eld-
erly foot [38,39]. Irrespective of the underlying cause of
poorly-fitting footwear, there is evidence that wearing
shoes that are too small is associated with foot problems.In older people, wearing shoes substantially narrower
than the foot is associated with corns on the toes, hallux
valgus deformity and foot pain, whereas wearing shoes
shorter than the foot is associated with lesser toe de-
formity [40]. Furthermore, a survey of 227 older women
revealed that 61% reported foot pain when wearing
shoes (most commonly in the forefoot and toes), and
that those with foot pain exhibited a broader forefoot
than those without pain [41].
In Australia, the Department of Veterans’ Affairs
(DVA), as part of the Rehabilitation Appliances Program,
covers the costs of medical grade footwear for veterans
who have severe foot deformity (defined as feet that can-
not be accommodated in regular ‘off-the-shelf ’ foot-
wear). Footwear provision is one of the most common
podiatry interventions. An analysis of 1996 to 1997 DVA
data indicated that out of the total podiatry DVA popu-
lation who had received a podiatry intervention (n =
4,418), 3,227 (73%) received new medical grade footwear
[42]. However, there is also a high demand for footwear
by veterans who have foot pain but do not have severely
deformed feet. In this context, it is likely that there are a
substantial number of veterans who could benefit from
the provision of more appropriate footwear. Such an
intervention may also reduce the need for frequent, on-
going maintenance foot care provided by podiatrists
under the DVA scheme.
Therefore, the aim of this study is to evaluate the ef-
fectiveness of relatively low-cost but good quality,
custom-fitted footwear to DVA clients with foot pain
who do not currently meet the structural deformity cri-
teria for medical grade footwear.
Methods
The trial has been registered on the Australian New
Zealand Clinical Trials Registry (ACTRN12612000322831).
Ethical approval
The Australian DVA Human Research Ethics Committee
provided ethical approval (approval number E012/005
[5.1]) and the La Trobe University Human Ethics Com-
mittee formally accepted this approval (E012/004). All
participants will provide written informed consent prior
to enrolment. Ethical standards will adhere to the Na-
tional Health and Medical Research Council (NHMRC)
National Statement [43] and the World Medical As-
sociation's Declaration of Helsinki [44]. Publications as-
sociated with the trial will be formatted according to the
Consolidated Standards of Reporting Trials (CONSORT)
2010 statement [45,46].
Design
This study is a two-group randomized controlled trial with
a 16 week prospective follow-up (Figure 1). Participants
Figure 1 Trial profile.
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group or the intervention group [47]. Permuted block
randomization with random block sizes (stratified by sex
[48]) will be undertaken using an interactive voice re-
sponse telephone service provided by the NHMRC Clin-
ical Trials Centre at the University of Sydney, New South
Wales, Australia to ensure allocation concealment. Due to
the nature of the intervention, it will not be possible to
blind the participants or investigators. However, the pri-
mary outcome measure is administered as a self-
completion questionnaire and will be entered into the
database by an investigator blinded to group allocation.
Participant recruitment, screening and eligibility criteria
The geocoding feature of the DVA database will be used
to identify veterans currently receiving podiatry treat-
ments who are residing in Melbourne, Victoria. From this
group of veterans, the DVA Departmental ManagementInformation System will be used to identify those who
have not been issued with medical grade footwear within
the last five years, by excluding veterans who have docu-
mented a footwear-related item number during this period
(item numbers F604, F605, F606, F611, F612, F625, F660,
F661 F670, F671, F615 or F616). The remaining veterans
will form the primary recruitment source and will be
mailed an information package about the study, along
with an invitation to contact the research team by either
return mail or by telephone. Database recruitment will be
complemented by running advertisements in DVA news-
letters and placing posters at Returned and Services
Leagues Clubs in the surrounding suburbs.
During the initial telephone contact with participants,
a member of the research team will determine each vet-
eran’s eligibility by structured interview. To be included
in the study, veterans will need to meet the following in-
clusion criteria:
Figure 2 Dr ComfortW footwear to be used in the study for
men (‘Brian’ style).
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(ii) be a current DVA Gold Card client not eligible for
medical grade footwear;
(iii)have received podiatry treatment on at least three
occasions in the past five years;
(iv) have disabling foot pain, using the case definition
of the Manchester Foot Pain and Disability Index
(MFPDI) [49] proposed by Roddy et al. [50]. The
MFPDI consists of 19 statements prefaced by the
phrase ‘Because of pain in my feet’, formalized
under three constructs: functional limitation (10
items), pain intensity (five items), and personal
appearance (two items), with three possible
answers: ‘none of the time’ (score = 0), ‘some days’
(score = 1), and ‘most days/every day’ (score = 2).
The Roddy et al. definition requires at least one of
the ten functional limitation items to be documented
on most/every day(s) in the last month;
(v) have persistent foot pain, defined as foot pain
present for at least 12 weeks, and;
(vi) be capable of understanding the English language
in verbal and written form.
Veterans will not be eligible for inclusion in the study
if they:
(i) are currently residing in a residential aged care
facility;
(ii) have diabetes and a history of foot ulceration (or
current foot ulceration) or diabetic peripheral
neuropathy (diagnosed with the 5.07 Semmes-
Weinstein monofilament, using the International
Working Group on the Diabetic Foot protocol [51]);
(iii)have a neurodegenerative disorder (for example,
Parkinson’s disease);
(iv) have had a lower limb or partial foot amputation
(although single toe amputations will be permitted);
(v) have been prescribed contoured foot orthoses
within the past three months (although simple flat
insoles will be permitted, as will contoured foot
orthoses prescribed more than three months ago);
(vi) are currently wearing the intervention footwear, or;
(vii) have cognitive impairment (defined as a score of <
7 on the Short Portable Mental Status
Questionnaire [52]).
Intervention group
The intervention group will continue to receive regular
podiatry treatment as clinically required. This will typic-
ally include toenail maintenance and scalpel debride-
ment of hyperkeratotic lesions (corns and calluses). In
addition, they will be provided with good quality, off-
the-shelf footwear (Dr ComfortW Vasyli Medical, Labra-
dor, Queensland, Australia). Men will receive the ‘Brian’style and women will receive the ‘Annie’ style (see
Figures 2 and 3). Both styles are available in three width
fittings (medium, wide, extra-wide) and feature a
stretchable LycraW upper with VelcroW closure and a re-
movable, flat cushioned insole. These shoes have been
selected as they meet all commonly-used criteria for ap-
propriate footwear (such as a low heel, appropriate
fixation and adequate depth to accommodate toe de-
formities) [53-57]. Due to sex differences in foot dimen-
sions (and therefore the dimensions of the lasts the
shoes are constructed from) the ‘Brian’ style has a rela-
tively broader fit than the ‘Annie’ style. However, both
the heel height and toe spring are the same for shoes of
equivalent length across the two styles.
The research staff will measure participants’ feet using
a Brannock DeviceW (Brannock Device Co, Inc., Liver-
pool, New York, USA) to ensure appropriate length and
width, using the fitting protocol recommended by the
footwear manufacturer [58]. Intervention group partici-
pants who wear flat insoles (or have been wearing
contoured foot orthoses for more than three months) in
their current footwear will be permitted to wear them in
their study footwear, provided that the fit of the shoes is
considered to be appropriate.
Control group
The control group will continue to receive regular po-
diatry treatment as clinically required. This will typically
include toenail maintenance and scalpel debridement of
hyperkeratotic lesions (corns and calluses). Upon com-
pletion of the trial, they will be provided with the same
footwear used in the intervention group.
Baseline assessments
Participant characteristics will be collected by structured
interview at the baseline assessment and will include
age, sex, height, weight, waist circumference, hip cir-
cumference, country of birth, education, major medical
Figure 3 Dr ComfortW footwear to be used in the study for
women (‘Annie’ style).
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cigarette smoking history. The following questionnaires
and clinical tests will also be administered:
(i) foot pain characteristics, including duration (in
months) and location, using a standardized foot
diagram;
(ii) presence and severity of hallux valgus, assessed
using the Manchester Scale [59];
(iii) foot structure and presence of hyperkeratotic
lesions (corns and calluses), documented with
three-dimensional clinical photographs using the
FotoScan™ 3D foot scanner (Precision 3D Limited,
Weston-super-Mare, UK);
(iv) the Pain Catastrophizing Scale, a questionnaire
containing 13 items reflecting elevated negative
cognitive responses to pain [60];
(v)the short version of the Geriatric Depression Scale, a
15-item depression screening tool that has been
specifically validated in older people [61,62];
(vi) footwear assessment, using selected components of
the recently developed Footwear Assessment Tool
[57], and;
(vii) physical activity levels, using the Incidental and
Planned Activity Questionnaire [63].
In addition, participants allocated to the footwear inter-
vention group will be asked to complete six 100 mm visual
analogue scales to ascertain their perceptions of: (i) the im-
mediate level of comfort of the footwear (using the anchors
‘extremely uncomfortable’ and ‘extremely comfortable’
[64]); (ii) the attractiveness of the footwear (using the an-
chors ‘extremely unattractive’ and ‘extremely attractive’);
(iii) how attractive they think other people would find the
footwear (using the anchors ‘extremely unattractive’ and
‘extremely attractive’); (iv) how well the shoes fit (using the
anchors ‘poorest fit possible’ and ‘best fit possible’); (v) how
easy it is to put the shoes on and take them off (using theanchors ‘most difficult as possible’ and ‘as easy as imagin-
able’) and; (vi) how heavy the shoes are (using the anchors
‘extremely light’ and ‘extremely heavy’).
The perceived therapeutic value of the shoes will be
assessed using responses to the statement ‘I believe that
the shoes provided to me can reduce the severity of my
foot pain’, with a five-point Likert scale ranging from
‘strongly disagree’ to ‘strongly agree’. In addition, two
100 mm visual analogue scales will be used to ascertain
expectations of pain reduction associated with the foot-
wear, with the questions ‘With your shoes, do you expect
to have less or more pain in the skin of your feet and/or
ankles, during activities like standing and/or walking?’
and ‘With your shoes, do you expect to have less or
more pain in the muscles and joints of your feet and/or
ankles, during activities like standing and/or walking?’,
both using the anchors ‘much less’ and ‘much more’.
These questions are derived from the Monitor Ortho-
pedic Shoes questionnaire [65], and will be used to pre-
dict adherence to, and effectiveness of, the footwear
intervention at the completion of the study.
Primary outcome measure
The primary outcome measure will be the pain domain
of the Foot Health Status Questionnaire (FHSQ). The
FHSQ consists of 13 questions reflecting four foot
health-related domains: foot pain, foot function, foot-
wear, and general foot health [66]. The FHSQ pain do-
main comprises four questions, with higher scores
representing better foot health (that is, 100 = best foot
health and 0 = worst foot health). The FHSQ pain do-
main demonstrates a high degree of content, criterion,
and construct validity (Cronbach α = 0.88), high retest
reliability (intraclass correlation coefficient = 0.86) and
has been used as an outcome measure in clinical trials
for a range of foot disorders [67]. Previous research indi-
cates that the minimal important difference for this
measure is 12.5 points [68]. The FHSQ pain domain will
be measured at baseline and at 4, 8, 12 and 16 weeks,
with the primary endpoint being the 16 week score.
Secondary outcome measures
Secondary outcome measures will be documented at
baseline and 16 weeks and will include:
(i) the function domain of the FHSQ [3];
(ii)the functional limitation, pain intensity and concern
about appearance subscales of the MFPDI [49];
(iii) the number of DVA podiatry treatments required
during the study period;
(iv) general health-related quality of life, assessed with
the Short Form 12® Version 2.0 [69];
(v)the number of falls experienced during the follow-up
period;
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test [70];
(vii) presence of hyperkeratotic lesions (corns and
calluses);
(viii) number of participants using co-interventions to
relieve foot pain (such as oral non-steroidal
antiinflammatory medications, topical medications
and visits to other health-care practitioners),
documented using a diary at 4, 8, 12 and 16 weeks,
and;
(ix)participants’ perception of overall treatment effect
at week 16, assessed with the question ‘Overall, how
has your foot pain changed since the start of the
study?’ with a five-point Likert scale response
(‘marked worsening’, ‘moderate worsening’, ‘same’,
‘moderate improvement’, or ‘marked improvement’).
For the purpose of analysis, this scale will then be
dichotomized, where ‘success’ is defined as marked
or moderate improvement on this scale.
Sample size
The sample size for the study has been calculated based
on the pain domain of the FHSQ as the primary outcome
measure [66]. Using a minimal important difference of
12.5 and a standard deviation of 23 obtained from a pre-
vious study [68], and assuming a 10% drop-out rate, the
required sample size is 60 per group (power = 80%). We
believe that the 10% drop-out rate is reasonable, as our
recent randomized controlled trial of a multifaceted po-
diatry intervention to prevent falls in older people had a
drop-out rate of less than 5% over a much longer period
of follow-up (12 months) [71]. The extra precision pro-
vided by covariate analysis was conservatively ignored
when performing this calculation.
Evaluation of adherence
Adherence to the intervention will be documented at 4,
8, 12 and 16 weeks by asking participants on how many
days (and for how many hours) they have worn their
footwear, on average, in the past month.
Complications and adverse events
Complications and adverse events associated with the
intervention are unlikely. However, the questionnaires at
the 4, 8, 12 and 16 week follow-ups will provide partici-
pants with an opportunity to report any difficulties they
have with the footwear, and all adverse events will be
reported in the final manuscript.
Statistical analysis
Statistical analysis will be undertaken using SPSS version
20.0 (IBM Corp, NY, USA). All analyses will be
conducted on an intention-to-treat principle using all
randomized participants. Multiple imputation will beused to replace any missing data using five iterations,
with age, baseline scores, and group allocation as predic-
tors [72]. Demographic characteristics and baseline data
will be summarized by descriptive statistics. Continuous
data will be explored for normality using standard tests
to satisfy the assumptions of parametric statistics. If data
are found to be not normally distributed, transformation
will be attempted using conventional techniques [73].
However, if data are still not normally distributed after
transformation, non-parametric statistical tests will
be used. Continuously-scored primary and secondary
outcome measures with a normal distribution will be
compared between groups using a linear regression tech-
nique with baseline scores, adjusted for by the analysis
of covariance model [74,75]. Nominal and ordinal scaled
data will be compared using chi-square analyses (or
Fisher's exact test where appropriate) and Mann–Whit-
ney U-tests, respectively. Effect sizes will be determined
using Cohen’s d [76] for continuous data and relative
risks for nominal data. Statistical significance for hypoth-
esis tests will be set at the conventional level of
α = 0.05.
Discussion
Footwear plays an important role in the maintenance of
foot health and mobility in older people, and it has long
been recognized that suboptimal footwear can be detri-
mental [77,78]. The provision of appropriate footwear,
therefore, has considerable potential to reduce pain and
improve health-related quality of life in this age-group.
Although several studies have been undertaken to assess
the effectiveness of footwear interventions in reducing
foot pain in people with rheumatoid arthritis and other
degenerative foot disorders [79-81], none have focused
on the general veteran community. The study outlined
in this protocol is, therefore, novel in that it targets a
specific group of veterans (those ineligible for medical
grade footwear) and uses generic, off-the-shelf footwear
as the intervention.
Participants will be followed up at four-weekly intervals
up to 16 weeks. This is longer than previous footwear
intervention studies, which have employed 8 week [79] or
12 week [80,81] follow-up periods. We are, therefore,
confident that the duration of the study is sufficient to de-
tect differences between the groups, if they exist. Further-
more, previous footwear studies have been limited to
single baseline and follow-up assessments [79-81],
whereas our study will incorporate five repeated measure-
ments for the primary outcome measure (baseline, 4
weeks, 8 weeks, 12 weeks and 16 weeks). This will provide
additional insight into the trajectory of any improvements
in participants’ foot pain. However, to address the issue of
multiple testing of serial measurements [82,83], we have
pre-specified 16 weeks as the primary end-point, and no
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be undertaken.
Poor adherence is a well-recognized problem with
footwear intervention studies [71,80,84] and has been at-
tributed to the unique role of footwear as both an item
of clothing and a health-related intervention [85]. We
expect that the level of adherence to the off-the-shelf
footwear in this study will be higher than that associated
with medical grade footwear, due to better cosmesis.
Furthermore, the initial postal invitation to take part in
the study will specify the type of footwear that will be
provided (accompanied by photographs), thereby provid-
ing veterans with an opportunity to decline participation
on the basis of dissatisfaction with the appearance of the
footwear. However, it is still likely that some participants
will not be satisfied with the footwear either at the point
of issue or during the follow-up period. The inclusion of
baseline questionnaires addressing participants’ immedi-
ate perceptions of the attractiveness, comfort and usabil-
ity of the footwear may provide useful insights into their
adherence during the trial.
There are three key limitations of the study design that
warrant careful consideration. Firstly, due to the nature
of the intervention, it will not be possible to blind partic-
ipants to their group allocation, nor will it be possible to
blind the investigators providing the intervention. Sec-
ondly, because the ‘usual care’ control group will receive
no additional treatment until the completion of the
study, there is a risk of what is often referred to as ‘re-
sentful demoralization’. That is, participants allocated to
the control group may be resentful of not receiving the
intervention, which may affect their adherence to the
tasks required of them in the study and systematically
influence their responses to the outcome measure ques-
tionnaires [86]. While this cannot be completely avoided,
it may be offset to some extent by the fact that the
control group participants will receive the intervention
footwear at the completion of the trial, free of charge -
footwear that they would not otherwise be eligible for
under the DVA program. One suggested approach to ad-
dress this issue is to document participant group alloca-
tion preference as a prognostic variable and consider
this in the statistical analysis [87]. However, this would
not be appropriate in our study, as it is unlikely that any
participants would prefer to wait 16 weeks for their foot-
wear rather than receiving it at the commencement of
the study. Finally, this trial has been pragmatically
designed to ensure that the findings can be easily trans-
lated into ‘real world’ situations, where off-the-shelf
footwear is most often purchased without clinical assess-
ment or diagnosis from foot health professionals. As
such, we have not restricted the inclusion criteria in re-
lation to the underlying cause of foot pain, so it is pos-
sible that our sample will include some participants withconditions that may not be amenable to treatment with
footwear.
Trial status
In summary, this study will be the first randomized con-
trolled trial investigating the effectiveness of off-the-shelf
footwear in reducing foot pain in Australian DVA clients
ineligible for medical grade footwear. The study findings
will be used to make evidence-based recommendations re-
garding the potential role of this intervention and will help
inform the footwear provision component of the Rehabili-
tation Appliances Program of the DVA. Recruitment of
participants commenced in October 2012 and final results
are expected to be available in November 2013.
Abbreviations
DVA: Department of Veterans’ Affairs; FHSQ: Foot Health Status
Questionnaire; MFPDI: Manchester Foot Pain and Disability Index.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
HBM and NF conceived the idea and obtained funding for the study. HBM,
NF and SEM designed the trial protocol. HBM drafted the manuscript. All
authors have read and approved the final manuscript.
Acknowledgements
This study is funded by the Australian Department of Veterans’ Affairs
(Applied Research Program ID: ARP1031). HBM is currently a National Health
and Medical Research Council Senior Research Fellow (ID: 1020925). We
would like to thank Jane Fyfield (National Medical Advisor, Health Strategy
and Gerontology, Australian Department of Veterans’ Affairs) for her
assistance, Matt Barkley and Craig Truscott (Vasyli Medical) for subsidizing the
footwear used in the study and assisting with training of research assistants,
and Maria Auhl and Sonja Ristevski (research assistants) for assisting with the
final development of the protocol.
Author details
1Lower Extremity and Gait Studies Program, Faculty of Health Sciences,
La Trobe University, Bundoora 3086, Victoria, Australia. 2Department of
Podiatry, Faculty of Health Sciences, La Trobe University, Bundoora 3086,
Victoria, Australia.
Received: 21 December 2012 Accepted: 4 April 2013
Published: 23 April 2013
References
1. Dunn JE, Link CL, Felson DT, Crincoli MG, Keysor JJ, McKinlay JB: Prevalence
of foot and ankle conditions in a multiethnic community sample of
older adults. Am J Epidemiol 2004, 159:491–498.
2. Menz HB, Tiedemann A, Kwan MMS, Plumb K, Lord SR: Foot pain in
community-dwelling older people: an evaluation of the Manchester Foot
Pain and Disability Index. Rheumatology 2006, 45:863–867.
3. Hill CL, Gill T, Menz HB, Taylor AW: Prevalence and correlates of foot pain
in a population-based study: the North West Adelaide Health Study.
J Foot Ankle Res 2008, 1:2.
4. White EG, Mulley GP: Footcare for very elderly people: a community
survey. Age Ageing 1989, 18:275–278.
5. Black JR, Hale WE: Prevalence of foot complaints in the elderly. J Am
Podiatr Med Assoc 1987, 77:308–311.
6. Cartwright A, Henderson G: More trouble with feet - a survey of the foot
problems and chiropody needs of the elderly. London: Department of Health
and Social Security, HMSO; 1986.
7. Benvenuti F, Ferrucci L, Guralnik JM, Gangemi S, Baroni A: Foot pain and
disability in older persons: an epidemiologic survey. J Am Geriatr Soc
1995, 43:479–484.
Menz et al. Trials 2013, 14:106 Page 8 of 9
http://www.trialsjournal.com/content/14/1/1068. Gorter KJ, Kuyvenhoven MM, deMelker RA: Nontraumatic foot complaints
in older people. A population-based survey of risk factors, mobility, and
well-being. J Am Podiatr Med Assoc 2000, 90:397–402.
9. Bowling A, Grundy E: Activities of daily living: changes in functional
ability in three samples of elderly and very elderly people. Age Ageing
1997, 26:107–114.
10. Barr ELM, Browning C, Lord SR, Menz HB, Kendig H: Foot and leg problems
are important determinants of functional status in community-dwelling
older people. Disabil Rehabil 2005, 27:917–923.
11. Menz HB, Lord SR: The contribution of foot problems to mobility
impairment and falls in older people. J Am Geriatr Soc 2001,
49:1651–1656.
12. Gabell A, Simons MA, Nayak USL: Falls in the healthy elderly: predisposing
causes. Ergonomics 1985, 28:965–975.
13. Tinetti ME, Speechley M, Ginter SF: Risk factors for falls among elderly
persons living in the community. New Eng J Med 1988, 319:1701–1707.
14. Koski K, Luukinen H, Laippala P, Kivela S-L: Physiological factors and
medications as predictors of injurious falls by elderly people: a
prospective population-based study. Age Ageing 1996, 25:29–38.
15. Leveille SG, Bean J, Bandeen-Roche K, Jones R, Hochberg M, Guralnik JM:
Musculoskeletal pain and risk of falls in older disabled women living in
the community. J Am Geriatr Soc 2002, 50:671–678.
16. Menz HB, Morris ME, Lord SR: Foot and ankle risk factors for falls in older
people: a prospective study. J Gerontol A Biol Sci Med Sci 2006,
61A:M866–870.
17. Chen J, Devine A, Dick IM, Dhaliwal SS, Prince RL: Prevalence of lower
extremity pain and its association with functionality and quality of life in
elderly women in Australia. J Rheumatol 2003, 30:2689–2693.
18. Elewski BE: The effect of toenail onychomycosis on patient quality of life.
Int J Dermatol 1997, 36:754–756.
19. Roseeuw D: Achilles foot screening project: preliminary results of
patients screened by dermatologists. J Eur Acad Dermatol Venereol 1999,
12:S6–9.
20. Schein JR, Gause D, Stier DM, Lubeck DP, Bates MM, Fisk R: Onychomycosis.
Baseline results of an observational study. J Am Podiatr Med Assoc 1997,
87:512–519.
21. Thordarson DB, Ebramzadeh E, Rudicel SA, Baxter A: Age-adjusted baseline
data for women with hallux valgus undergoing corrective surgery. J Bone
Joint Surg Am 2005, 87A:66–75.
22. Lazarides SP, Hildreth A, Prassanna V, Talkhani I: Association amongst
angular deformities in hallux valgus and impact of the deformity in
health-related quality of life. Foot Ankle Surg 2005, 11:193–196.
23. Bergin SM, Munteanu SE, Zammit GV, Nikolopoulos N, Menz HB: Impact of
first metatarsophalangeal joint osteoarthritis on health-related quality of
life. Arthritis Care Res 2012, 64:1691–1698.
24. Irving DB, Cook JL, Young MA, Menz HB: Impact of chronic plantar heel
pain on health-related quality of life. J Am Podiatr Med Assoc 2008,
98:283–289.
25. Brodie BS, Rees CL, Robins DJ, Wilson AFJ: Wessex Feet: a regional foot
health survey, Volume I: The survey. Chiropodist 1988, 43:152–165.
26. Garrow AP, Silman AJ, Macfarlane GJ: The Cheshire Foot Pain and
Disability Survey: a population survey assessing prevalence and
associations. Pain 2004, 110:378–384.
27. Greenberg L, Davis H: Foot problems in the US. The National Health
Interview Survey. J Am Podiatr Med Assoc 1990, 1993(83):475–483.
28. Menz HB, Morris ME: Determinants of disabling foot pain in retirement
village residents. J Am Podiatr Med Assoc 2005, 95:573–579.
29. Leveille SG, Guralnik JM, Ferrucci L, Hirsch R, Simonsick E, Hochberg MC:
Foot pain and disability in older women. Am J Epidemiol 1998,
148:657–665.
30. White E, Mulley G: Footwear worn by the over 80s: a community survey.
Clin Rehabil 1989, 3:23–25.
31. Munro BJ, Steele JR: Household-shoe wearing and purchasing habits - a
survey of people aged 65 years and older. J Am Podiatr Med Assoc 1999,
89:506–514.
32. Jessup RL: Foot pathology and inappropriate footwear as risk factors for
falls in a subacute aged-care hospital. J Am Podiatr Med Assoc 2007,
97:213–217.
33. Burns S, Leese G, McMurdo M: Older people and ill-fitting shoes. Postgrad
Med J 2002, 78:344–346.34. Nixon BP, Armstrong DG, Wendell C, Vazquez JR, Rabinovich Z: Do US
veterans wear appropriately sized shoes? The Veterans Affairs shoe size
selection study. J Am Podiatr Med Assoc 2006, 96:290–292.
35. Chaiwanichsiri D, Tantisiriwat N, Janchai S: Proper shoe sizes for Thai
elderly. Foot 2008, 18:186–191.
36. Joyce P: Women and their shoes: attitudes, influences and behavior. Br J
Podiat 2000, 3:111–115.
37. Seferin M, Van der Linden J: Protection or pleasure: female footwear.
Work 2012, 41:290–294.
38. Chantelau E, Gede A: Foot dimensions of elderly people with and without
diabetes mellitus - a data basis for shoe design. Gerontology 2002,
48:241–244.
39. Mickle KJ, Munro BJ, Lord SR, Menz HB, Steele JR: Foot shape of older
people: implications for shoe design. Footwear Sci 2010, 2:131–139.
40. Menz HB, Morris ME: Footwear characteristics and foot problems in older
people. Gerontology 2005, 51:346–351.
41. Paiva de Castro A, Rebelatto JR, Aurichio TR: The relationship between foot
pain, anthropometric variables and footwear among older people.
Appl Ergon 2010, 41:93–97.
42. Frescos N, Menz HB: Foot health service provision by the Australian
Department of Veterans' Affairs: do major podiatric medical
interventions reduce the number of maintenance treatments? J Am
Podiatr Med Assoc 2007, 97:469–474.
43. NHMRC: National statement on ethical conduct in human research. Canberra:
Australian Government; 2007.
44. Ethical principles for medical research involving human subjects: http://
www.wma.net/en/30publications/10policies/b3/.
45. Schulz KF, Altman DG, Moher D: CONSORT 2010 statement: updated
guidelines for reporting parallel group randomised trials. BMJ 2010, 340:
c332.
46. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ,
Elbourne D, Egger M, Altman DG: CONSORT 2010 explanation and
elaboration: updated guidelines for reporting parallel group randomised
trials. BMJ 2010, 340:c869.
47. Altman DG, Bland JM: Statistics notes. Treatment allocation in controlled
trials: why randomise? BMJ 1999, 318:1209.
48. Altman DG, Bland JM: How to randomise. BMJ 1999, 319:703–704.
49. Garrow AP, Papageorgiou AC, Silman AJ, Thomas E, Jayson MIV, Macfarlane
GJ: Development and validation of a questionnaire to assess disabling
foot pain. Pain 2000, 85:107–113.
50. Roddy E, Muller S, Thomas E: Defining disabling foot pain in older adults:
further examination of the Manchester Foot Pain and Disability Index.
Rheumatology 2009, 48:992–996.
51. Apelqvist JBK, van Houtum WH, Nabuurs-Franssen MH, Schaper N:
International consensus and practical guidelines on the management
and the prevention of the diabetic foot. Diabetes Metab Res Rev 2000,
16(Suppl 1):S84–92.
52. Pfeiffer E: A short portable mental status questionnaire for the
assessment of organic brain deficit in elderly patients. J Am Geriatr Soc
1975, 23:433–441.
53. Nancarrow S: Footwear suitability scale: a measure of shoe fit for people
with diabetes. Australas J Podiatr Med 1999, 33:57–62.
54. Menz HB, Sherrington C: The Footwear Assessment Form: a reliable
clinical tool for the evaluation of footwear characteristics of relevance to
postural stability in older adults. Clin Rehabil 2000, 14:657–664.
55. Williams A: Footwear assessment and management. Podiatry Now
2006:S1–8.
56. Healthy Footwear Guide: http://www.healthy-footwear-guide.com.
57. Barton CJ, Bonanno D, Menz HB: Development and evaluation of a tool
for the assessment of footwear characteristics. J Foot Ankle Res 2009, 2:10.
58. Dr Comfort Shoe Fitting Techniques: http://www.youtube.com/watch?
v=XxkUZfZX7Ek.
59. Garrow AP, Papageorgiou A, Silman AJ, Thomas E, Jayson MI, Macfarlane GJ:
The grading of hallux valgus. The Manchester Scale. J Am Podiatr Med
Assoc 2001, 91:74–78.
60. Sullivan MJ, Bishop SR, Pivik J: The pain catastrophizing scale:
development and validation. Psychol Assess 1995, 7:524–532.
61. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO:
Development and validation of a geriatric depression screening scale: a
preliminary report. J Psychiatr Res 1983, 17:37–49.
Menz et al. Trials 2013, 14:106 Page 9 of 9
http://www.trialsjournal.com/content/14/1/10662. Sheikh JI, Yesavage JA: Geriatric Depression Scale (GDS): recent evidence
and development of a shorter version. In Clinical Gerontology: A Guide to
Assessment and Intervention. Edited by Brink TL. New York: The Haworth
Press; 1986:165–173.
63. Delbaere K, Hauer K, Lord SR: Evaluation of the incidental and planned
activity questionnaire for older people. Br J Sports Med 2010,
44:1029–1034.
64. Mills K, Blanch P, Vicenzino B: Identifying clinically meaningful tools for
measuring comfort perception of footwear. Med Sci Sports Exerc 2010,
42:1966–1971.
65. van Netten JJ, Hijmans JM, Jannink MJ, Geertzen JH, Postema K:
Development and reproducibility of a short questionnaire to measure
use and usability of custom-made orthopaedic shoes. J Rehabil Med 2009,
41:913–918.
66. Bennett P, Patterson C, Wearing S, Baglioni T: Development and validation
of a questionnaire designed to measure foot-health status. J Am Podiatr
Med Assoc 1998, 88:419–428.
67. Riskowski JL, Hagedorn TJ, Hannan MT: Measures of foot function, foot
health, and foot pain. Arthritis Care Res 2011, 63:S229–239.
68. Landorf KB, Radford JA, Hudson S: Minimal important difference (MID) of
two commonly used outcome measures for foot problems. J Foot Ankle
Res 2010, 3:7.
69. Ware J Jr, Kosinski M, Keller SD: A 12-item Short Form health survey:
construction of scales and preliminary tests of reliability and validity.
Med Care 1996, 34:220–233.
70. Podsialdo D, Richardson S: The timed ‘Up and Go’: a test of basic
functional mobility for frail elderly persons. J Am Geriatr Soc 1991,
39:142–148.
71. Spink MJ, Menz HB, Fotoohabadi MR, Wee E, Landorf KB, Hill KD, Lord SR:
Effectiveness of a multifaceted podiatry intervention to prevent falls in
community dwelling older people with disabling foot pain: randomized
controlled trial. BMJ 2011, 342:d3411.
72. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM,
Carpenter JR: Multiple imputation for missing data in epidemiological
and clinical research: potential and pitfalls. BMJ 2009, 338:b2393.
73. Bland JM, Altman DG: Transforming data. BMJ 1996, 312:770.
74. Vickers AJ, Altman DG: Statistics notes: analysing controlled trials with
baseline and follow-up measurements. BMJ 2001, 323:1123–1124.
75. Twisk J, Proper K: Evaluation of the results of a randomized controlled
trial: how to define changes between baseline and follow-up. J Clin
Epidemiol 2004, 57:223–228.
76. Cohen J: Statistical power analysis for the behavioral sciences. 2nd edition.
Hillsdale, NJ: Erlbaum; 1988.
77. Finlay OE: Footwear management in the elderly care program.
Physiotherapy 1986, 72:172–178.
78. Edelstein JE: If the shoe fits: footwear considerations for the elderly.
Phys Occup Ther Geriatr 1987, 5:1–16.
79. Fransen M, Edmonds J: Off-the-shelf orthopedic footwear for people with
rheumatoid arthritis. Arthritis Care Res 1997, 10:250–256.
80. Williams AE, Rome K, Nester CJ: A clinical trial of specialist footwear for
patients with rheumatoid arthritis. Rheumatology 2007, 46:302–307.
81. Jannink MJ, Izerman MJ, Groothius-Oudshoorn K, Stewart RE, Groothoff JW,
Lankhorst GJ: Use of orthopedic shoes in patients with degenerative
disorders of the foot. Arch Phys Med Rehabil 2005, 86:687–692.
82. Matthews JN, Altman DG, Campbell MJ, Royston P: Analysis of serial
measurements in medical research. BMJ 1990, 300:230–235.
83. Bender R, Lange S: Adjusting for multiple testing - when and how? J Clin
Epidemiol 2001, 54:343–349.
84. Knowles EA, Boulton AJ: Do people with diabetes wear their prescribed
footwear? Diabet Med 1996, 13:1064–1068.
85. Williams AE, Nester CJ, Ravey MI, Kottink A, Klapsing MG: Women's
experiences of wearing therapeutic footwear in three European
countries. J Foot Ankle Res 2010, 3:23.86. Bradley C: Designing medical and educational intervention studies. A
review of some alternatives to conventional randomized controlled
trials. Diabetes Care 1993, 16:509–518.
87. Torgerson DJ, Klaber-Moffett J, Russell IT: Patient preferences in
randomised trials: threat or opportunity? J Health Serv Res Policy 1996,
1:194–197.
doi:10.1186/1745-6215-14-106
Cite this article as: Menz et al.: Effectiveness of off-the-shelf footwear in
reducing foot pain in Australian Department of Veterans’ Affairs
recipients not eligible for medical grade footwear: study protocol for a
randomized controlled trial. Trials 2013 14:106.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
